These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7022873)

  • 1. The value of ALG and ATG in clinical renal transplantation--recent European experience.
    Groth CG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):460-1. PubMed ID: 7022873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 3. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
    Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
    Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cadaveric allograft survival based on pretransplant nonspecific immunocompetence.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplant Proc; 1981 Sep; 13(3):1533-5. PubMed ID: 7029808
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses.
    Cosimi AB; Burton RC; Kung PC; Colvin R; Goldstein G; Lifter J; Rhodes W; Russell PS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):499-503. PubMed ID: 7022882
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged allograft survival of strong pretransplant immune responders treated with ATG.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplant Proc; 1981 Mar; 13(1 Pt 1):332-5. PubMed ID: 6455793
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of canine renal allograft survival by using a synthetic progestin in combination with azathioprine and antithymocyte globulin.
    Yellin JA; Enein AA; Goldson H; Hong J; Prince B; Sakai A; Kountz SL
    Surg Forum; 1977; 28():309-11. PubMed ID: 364721
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical value of the rosette inhibition test in renal allotransplantation.
    Cantaluppi A; Tarantino A; Donati D; Ponticelli C
    Transplant Proc; 1979 Mar; 11(1):379-81. PubMed ID: 377660
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of ATG-induced experimental transplantation tolerance with LS2616.
    Olausson M; Arvidsson N; Lukes D; Mjörnstedt L; Qi Z; Ekberg H; Gannedahl G; Tufveson G
    Transplant Proc; 1995 Dec; 27(6):3541-3. PubMed ID: 8540092
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical value of antilymphocyte antibodies.
    Cosimi AB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):462-8. PubMed ID: 7022874
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-DR, antithymocyte globulin (ATG) and survival of cadaveric renal allografts.
    Parsa I; Butt KM; Sutton AL; Adamsons RJ; Hong JH; Wertheim M; Butterman J; Shirani KZ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):495-8. PubMed ID: 7022881
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
    Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
    Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 15. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 16. Human T-lymphocyte receptors for sheep erythrocyte, antithymocyte (ATG), and anti-human brain globulins (AHB) in renal allograft recipients.
    Parsa I; Butt KM; Elberg AJ; Kountz SL; Satoh PS; Sutton A
    Transplant Proc; 1979 Jun; 11(2):1241-5. PubMed ID: 382498
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies.
    Thomas FT; Griesedieck C; Thomas J; Carver M; Whitley T; Warren R; Williams D
    Transplant Proc; 1984 Dec; 16(6):1561-3. PubMed ID: 6239426
    [No Abstract]   [Full Text] [Related]  

  • 18. Semi-specific immunosuppression in canine kidney allograft with I131 labelled ATG.
    Corman J; Smeesters C; Giroux L; St-Louis G; Leveille M; Lavigne CM; Lamoureux J; Jean G; Daloze P
    Transplant Proc; 1982 Dec; 14(4):656-8. PubMed ID: 6188256
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of ATG for reversal of acute allograft rejection.
    Nowygrod R; Appel G; Hardy MA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):469-72. PubMed ID: 7022875
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Burnett CM; Thomas FT
    Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.